Medical News

RSS

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

In an effort to ensure that Pennsylvania's citizens are protected against the H1N1 flu virus, the Department of Health will continue public vaccination clinics at all 60 state health centers every Saturday through Feb. 6 from 9 a.m. to noon.

23 Jan 2010

World Heart to sell nearly 1.5M shares of its common stock to raise $7.3M

World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has obtained commitments from institutional and individual investors to purchase approximately $7.3 million of its common stock in a private placement. WorldHeart has entered into a securities purchase agreement with the investors pursuant to which WorldHeart will sell an aggregate of 1,418,726 shares of its common stock and warrants to purchase up to 2,837,452 additional shares of common stock.

23 Jan 2010

Poll: Most say Congress should start again on health care

"A majority of Americans say President Obama and congressional Democrats should suspend work on the health care bill that has been on the verge of passage and consider alternatives that would draw more Republican support, a USA TODAY/Gallup Poll finds," USA Today reports.

23 Jan 2010

PhRMA funds a two-year research initiative to evaluate the safety and benefits of existing drugs

The Pink Sheet recently reported that the Pharmaceutical Research and Manufacturers of America (PhRMA) and individual drug firms, through the Foundation for the National Institutes of Health, are funding a two-year public/private research initiative to evaluate the safety and benefits of drugs that are currently on the market.

23 Jan 2010

MACI/ACI therapies could prevent total joint replacement in OA patients

Osteoarthritis (OA) is one of the ten most disabling diseases in the developed world and is set to become more of a financial burden on health services as average life expectancy increases.

23 Jan 2010

FDA's Ampyra approval wonderful news for people with MS experiencing walking problems

The U.S. Food and Drug Administration has approved the marketing of Ampyra™ (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.

23 Jan 2010

GOP to Dems: Slow down, start again

CQ Politics: "Fresh from his upset victory in Massachusetts, Republican Sen-elect Scott P. Brown said Thursday that he agreed with suggestions that Democrats should scrap their health care proposal and start over." Arriving at the Hill Thursday, "Brown, who will become the Senate's 41st Republican, depriving Democrats of their filibuster-proof majority — was greeted as a conquering hero by Senate Republicans" (1/21).

23 Jan 2010

FDA approves fampridine-SR drug for treatment of multiple sclerosis

The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis. Researchers at the University of Rochester Medical Center (URMC) have been evaluating the effects of the drug in MS for more than 10 years- it is the first medication shown to enhance some neurological functions in people with the disease - and their efforts helped pave the way for today's action by the FDA.

23 Jan 2010

HTDS evaluates business proposal ahead of dividend distribution

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) subsidiary Slavica Bio Chem recently announced entry into the stem cell bank development. An unsolicited business proposal is currently being evaluated by the company from an obstetrician type medical company. This company is engaged in a treatment for pre-term labor and induction of labor. These symptoms affect millions of people worldwide.

23 Jan 2010

Solos Endoscopy generates $125,791 in sales transactions for fourth-quarter of 2009

Solos Endoscopy, Inc. is pleased to announce the Company has generated $125,791 in sales transactions for the fourth quarter of 2009 versus $115,159 in sales transactions that Solos generated for the fourth quarter of 2008, which is a 9 percent increase.

23 Jan 2010

Tax characteristics of Cogdell Spencer's 2009 dividends

Cogdell Spencer Inc. announced today the tax characteristics of its 2009 dividends. We are releasing this information to assist those required to distribute Form 1099s on the Company's dividend. This release is based on an estimate of "earnings and profits" as defined by the Internal Revenue Service. No material change in these classifications is expected.

23 Jan 2010

Heart murmurs in pediatric patients is not a serious condition, says physician

Your 3-year-old's doctor discovers a heart murmur during a visit for a mild cold with fever and recommends referral to a pediatric cardiologist. You worry and wonder how your healthy, active child could possibly have a heart problem.

23 Jan 2010

Searching for consensus, Dems consider potential of paring back health reform

"Passage of a comprehensive [health] bill looked impossible after the Democrats' loss of a Senate seat in Massachusetts. As an alternative, lawmakers in both parties said, some pieces of the bills already passed by the House and the Senate could be pulled out and packaged together in a measure that would command broad support."

23 Jan 2010

Ampyra receives FDA approval for improving walking in MS patients

The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.

23 Jan 2010

Sonomax Hearing Healthcare enters into agreement with Benvest New Look Income Fund

Sonomax Hearing Healthcare Inc. is pleased to announce that it has entered into an agreement with Benvest New Look Income Fund, a Québec-based income trust, that will provide gross proceeds to Sonomax of approximately $1.74 million in non-dilutive capital, concurrent with a corporate reorganization of Sonomax.

23 Jan 2010

Complete Genomics receives 2009 Red Herring Global 100 award

Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it has been selected as a 2009 Red Herring Global 100 award winner. The company was also recognized as a 2009 Red Herring North America 100 award winner earlier last year.

23 Jan 2010

Opinion: Haiti relief; WHO response to H1N1

An Economist editorial examines the relief and recovery efforts in Haiti and the "vital" importance of planning for rebuilding the country "before the world's generosity turns to cynicism. Fortunately there is a blueprint, drawn up by Haiti's government and presented to donors last year. It calls for investment to be targeted on infrastructure, basic services and combating soil erosion to make farmers more productive and the country less vulnerable to hurricanes. The pressing question is who should do it and how."

23 Jan 2010

Biovail comments on Teva Pharmaceutical's proposed Budeprion XL trial

Biovail Corporation today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL® 300 mg, Biovail’s FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva’s generic formulation of the drug. The trial was described in a Dow Jones Newswire article dated December 2, 2009.

22 Jan 2010

USPTO issues new patent for Advaxis' intellectual property portfolio

The U.S. Patent and Trademark Office (USPTO) issued today patent 7,635,479, "Compositions and Methods for Enhancing the Immunogenicity of Antigens,” by Dr. Yvonne Paterson, et al, which is assigned to the Trustees of the University of Pennsylvania and licensed to Advaxis, Incorporated (OTCBB: ADXS).

22 Jan 2010

Connecticut extends contract with ValueOptions to administer behavioral health services to young people

The state of Connecticut has extended its contract with ValueOptions® to administer public behavioral health services to 360,000 children and adults throughout the state.

22 Jan 2010

Medical News

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

World Heart to sell nearly 1.5M shares of its common stock to raise $7.3M

Poll: Most say Congress should start again on health care

PhRMA funds a two-year research initiative to evaluate the safety and benefits of existing drugs

MACI/ACI therapies could prevent total joint replacement in OA patients

FDA's Ampyra approval wonderful news for people with MS experiencing walking problems

GOP to Dems: Slow down, start again

FDA approves fampridine-SR drug for treatment of multiple sclerosis

HTDS evaluates business proposal ahead of dividend distribution

Solos Endoscopy generates $125,791 in sales transactions for fourth-quarter of 2009

Tax characteristics of Cogdell Spencer's 2009 dividends

Heart murmurs in pediatric patients is not a serious condition, says physician

Searching for consensus, Dems consider potential of paring back health reform

Ampyra receives FDA approval for improving walking in MS patients

Sonomax Hearing Healthcare enters into agreement with Benvest New Look Income Fund

Complete Genomics receives 2009 Red Herring Global 100 award

Opinion: Haiti relief; WHO response to H1N1

Biovail comments on Teva Pharmaceutical's proposed Budeprion XL trial

USPTO issues new patent for Advaxis' intellectual property portfolio

Connecticut extends contract with ValueOptions to administer behavioral health services to young people

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News